Free Trial
NASDAQ:ZIMV

ZimVie (ZIMV) Stock Price, News & Analysis

ZimVie logo
$10.24 +0.23 (+2.30%)
As of 02:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About ZimVie Stock (NASDAQ:ZIMV)

Key Stats

Today's Range
$9.92
$10.26
50-Day Range
$8.28
$10.01
52-Week Range
$8.15
$22.40
Volume
73,397 shs
Average Volume
191,769 shs
Market Capitalization
$285.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.33
Consensus Rating
Moderate Buy

Company Overview

ZimVie Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

ZIMV MarketRank™: 

ZimVie scored higher than 47% of companies evaluated by MarketBeat, and ranked 613th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ZimVie has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    ZimVie has only been the subject of 3 research reports in the past 90 days.

  • Read more about ZimVie's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ZimVie is -14.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ZimVie is -14.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    ZimVie has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about ZimVie's valuation and earnings.
  • Percentage of Shares Shorted

    1.95% of the float of ZimVie has been sold short.
  • Short Interest Ratio / Days to Cover

    ZimVie has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ZimVie has recently increased by 7.50%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    ZimVie does not currently pay a dividend.

  • Dividend Growth

    ZimVie does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.95% of the float of ZimVie has been sold short.
  • Short Interest Ratio / Days to Cover

    ZimVie has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ZimVie has recently increased by 7.50%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    ZimVie has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for ZimVie this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added ZimVie to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ZimVie insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.01% of the stock of ZimVie is held by insiders.

  • Percentage Held by Institutions

    95.63% of the stock of ZimVie is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about ZimVie's insider trading history.
Receive ZIMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZimVie and its competitors with MarketBeat's FREE daily newsletter.

ZIMV Stock News Headlines

Wall Street Zen Upgrades ZimVie (NASDAQ:ZIMV) to "Strong-Buy"
Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.
ZimVie: Screening Cheap (Rating Upgrade)
ZimVie Inc. (ZIMV) Q1 2025 Earnings Call Transcript
See More Headlines

ZIMV Stock Analysis - Frequently Asked Questions

ZimVie's stock was trading at $13.95 at the beginning of 2025. Since then, ZIMV shares have decreased by 26.6% and is now trading at $10.24.

ZimVie Inc. (NASDAQ:ZIMV) issued its quarterly earnings data on Thursday, May, 8th. The company reported $0.27 EPS for the quarter, topping analysts' consensus estimates of $0.21 by $0.06. The firm had revenue of $112 million for the quarter, compared to analysts' expectations of $113.10 million. ZimVie had a positive trailing twelve-month return on equity of 5.53% and a negative net margin of 4.40%.
Read the conference call transcript
.

Shares of ZIMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ZimVie investors own include Chevron (CVX), Comcast (CMCSA), Bristol Myers Squibb (BMY), McKesson (MCK), Charles Schwab (SCHW), Edwards Lifesciences (EW) and Yum! Brands (YUM).

Company Calendar

Last Earnings
5/08/2025
Today
7/03/2025
Next Earnings (Estimated)
7/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:ZIMV
Fax
N/A
Employees
1,770
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$16.33
High Stock Price Target
$23.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+59.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
17.07
P/E Growth
N/A
Net Income
-$25.83 million
Pretax Margin
-3.55%

Debt

Sales & Book Value

Annual Sales
$449.75 million
Cash Flow
$1.93 per share
Price / Cash Flow
5.30
Book Value
$13.83 per share
Price / Book
0.74

Miscellaneous

Free Float
27,009,000
Market Cap
$285.18 million
Optionable
Optionable
Beta
2.07
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:ZIMV) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners